Cargando…
Prognostic impact of MYH9 expression on patients with acute myeloid leukemia
MYH9 expression has previously been demonstrated as an independent predictor of clinical outcome in solid tumors. However, the prognostic relevance of MYH9 expression in acute myeloid leukemia is still unclear. Here, we found high MYH9 expressers were seen more frequently in females and more frequen...
Autores principales: | Yu, Mengxia, Wang, Jinghan, Zhu, Zhijuan, Hu, Chao, Ma, Qiuling, Li, Xia, Yin, Xiufeng, Huang, Jiansong, Zhang, Ting, Ma, Zhixin, Zhou, Yile, Li, Chenying, Chen, Feifei, Chen, Jian, Wang, Yungui, Pan, Hanzhang, Wang, Dongmei, Jin, Jie |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5352077/ https://www.ncbi.nlm.nih.gov/pubmed/27437869 http://dx.doi.org/10.18632/oncotarget.10613 |
Ejemplares similares
-
Prognostic significance of huntingtin interacting protein 1 expression on patients with acute myeloid leukemia
por: Wang, Jinghan, et al.
Publicado: (2017) -
The combination effect of homoharringtonine and ibrutinib on FLT3-ITD mutant acute myeloid leukemia
por: Li, Xia, et al.
Publicado: (2017) -
Correction: The combination effect of homoharringtonine and ibrutinib on FLT3-ITD mutant acute myeloid leukemia
por: Li, Xia, et al.
Publicado: (2019) -
High Expression of TET1 Predicts Poor Survival in Cytogenetically Normal Acute Myeloid Leukemia From Two Cohorts
por: Wang, Jinghan, et al.
Publicado: (2018) -
High PARP-1 expression predicts poor survival in acute myeloid leukemia and PARP-1 inhibitor and SAHA-bendamustine hybrid inhibitor combination treatment synergistically enhances anti-tumor effects
por: Li, Xia, et al.
Publicado: (2018)